Assessing individual bioequivalence using the structural equation model

Statistics in Medicine

Volumn 22, Issue 6, 2003, Pages 901-912

  Carrasco, Josep Lluís ^a   Jover, Lluís ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Individual bioequivalence; Intersection union principle; Limits of bioequivalence; Partial likelihood analysis; Structural equation model

Indexed keywords

VERAPAMIL;

AREA UNDER THE CURVE; BIOEQUIVALENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPOTHESIS; REVIEW; SIGNAL NOISE RATIO; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL PARAMETERS;

BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; DRUG EVALUATION; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; THERAPEUTIC EQUIVALENCY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VERAPAMIL;

EID: 0037473207     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1452     Document Type: Review

References (35)

1. Anderson S, Hauck WW. Consideration of individual bioequivalence. Journal of Pharmacokinetics and Biopharmaceutics 1990; 18:259-274.
2. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry. Statistical Approaches to Establishing Equivalence. CDER, 2001.
3. Schall R, Luus HG. On population and individual bioequivalence. Statistics in Medicine 1993; 12:1109-1124.
4. Hyslop T, Hsuan F, Holder DJ. A small sample confidence interval approach to assess individual bioequivalence. Statistics in Medicine 2000; 19:2885-2897.
5. Kelly GE. Use of the structural equations model in assessing the reliability of a new measurement technique. Applied Statistics 1985; 34(3):258-263.
6. Tan CY, Iglewicz B. Measurement-methods comparisons and linear statistical relationship. Technometrics 1999; 41(3):192-201.
7. Dragalin V, Fedorov V. The total least squares method in individual bioequivalence evaluation. Biometrical Journal 2001; 43(4):399-420.
8. Cheng CL, van Ness JW. Statistical Regression with Measurement Error. Kendall's Library of Statistics, Arnold: London, 1999.
9. Cox DR. Partial likelihood. Biometrika 1975; 62:269-276.
10. Chinchilli VM, Esinhart JD, Miller WG. Partial likelihood analysis of within-unit variances in repeated measurement experiments. Biometrics 1995; 51(1):205-216.
11. Birch MW. A note on the maximum likelihood estimation of a linear structural relationship. Journal of the American Statistical Association 1964; 59:1175-1178.
12. Gleser LJ. A note on G.R. Dolby's unreplicated ultrastructural model. Biometrika 1985; 72:117-124.
13. Fuller WA. Measurement Error Models. Wiley: New York, 1987.
14. Lehman EL. Testing Statistical Hypotheses. 2nd edn. Wiley: New York, 1986.
15. Roy SN. On a heuristic method of test construction and its use in multivariate analysis. Annals of Mathematical Statistics 1953; 24:220-238
16. Wellek S. On a reasonable disaggregate criterion of population bioequivalence admitting of resampling-free testing procedures. Statistics in Medicine 2000; 19:2755-2767.
17. Schuirmann DJ. A comparison of the two one-sided test procedure and the power approach for assessing the equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmaceutics 1987; 15:657-680.
18. Gleser LJ. Confidence intervals for the slope in a linear errors-in-variables regression model. In Advances in Multivariate Statistical Analysis, Gupta K (ed.). D. Reidel: Dordrecht, 1987; 85-109.
19. Gleser LJ, Hwang JT. The non-existence of 100(1 - α)% confidence sets of finite expected diameter in errors-in-variables and related models. Annals of Statistics 1987, 15:1351-1362.
20. Berger RL, Hsu JC. Bioequivalence trials, intersection-union tests and equivalence confidence sets. Statistical Science 1996; 11(4):283-319.
21. Chinchilli VM. The assessment of individual and population bioequivalence. Journal of Biopharmaceutical Statistics 1996; 6:1-14.
22. Sheiner LB. Bioequivalence revisited. Statistics in Medicine 1992; 11:1777-1788
23. Holder DJ, Hsuan F. Moment-based criteria for determining bioequivalence. Biometrika 1993; 80(4):835-846.
24. Esinhart JD, Chinchilli VM. Extension to the use of tolerance intervals for the assessment of individual bioequivalence. Journal of the Biopharmaceutical Statistics 1994; 4(1):39-52.
25. Vuorinen J, Turunen J. A three-step procedure for assessing bioequivalence in the general mixed model framework. Statistics in Medicine 1996; 15(24):2635-2655.
26. Gould AL. A practical approach for evaluating population and individual bioequivalence. Statistics in Medicine 2000; 19(20):2721-2740.
27. Lin LI. Total deviation index for measuring individual agreement with applications in laboratory performance and bioequivalence. Statistics in Medicine 2000; 19:255-270.
28. Senn S. Statistical issues in bioequivalence. Statistics in Medicine 2001; 20:2785-2799.
29. Chen ML. Individual bioequivalence-a regulatory update. Journal of Biopharmaceutical Statistics 1997; 7(1):5-11.
30. Liu JP, Chow SC. Some thoughts on individual bioequivalence. Journal of Biopharmaceutical Statistics 1997; 7(1):41-48.
31. Vuorinen J. A practical approach for the assessment of bioequivalence under selected higher-order cross-over designs. Statistics in Medicine 1997; 16:2229-2243.
32. Hauschke D, Steinijans VW. The U.S. draft guidance regarding population and individual bioequivalence approaches: comments by a research-based pharmaceutical company. Statistics in Medicine 2000; 19: 2769-2774.
33. Endrenyi L, Hao Y. Asymmetry of the mean-variability tradeoff raises questions about the model in investigations of individual bioequivalence. International Journal of Clinical Pharmacology and Therapeutics 1998; 36(8): 450-457.
34. Hauck WW, Chen ML, Hyslop T, Patnaik R, Schuirmann D, Williams R. Mean difference vs. variability reduction: tradeoffs in aggregate measures for individual bioequivalence. International Journal of Clinical Pharmacology and Therapeutics 1996; 34(12):535-541.
35. Chen ML, Patnaik R, Hauck WW, Schuirmann DJ, Hyslop T, Williams R. An individual bioequivalence criterion: regulatory considerations. Statistics in Medicine 2000; 19:2821-2842.